Mercredi, 19 Décembre 2018
Dernières nouvelles
Principale » The Geron Corp. (GERN) Issues Earnings Results, Beats Estimates By $0.04 EPS

The Geron Corp. (GERN) Issues Earnings Results, Beats Estimates By $0.04 EPS

14 Novembre 2017

As of the latest earnings report the EPS was $-0.18 with 159.23M shares now outstanding.

Geron Corporation (NASDAQ:GERN) shares traded -5.34% down during most recent session to reach at the closing price of $1.95. The company had revenue of $0.16 million during the quarter, compared to analysts' expectations of $0.40 million. Previously Geron Corporation (NASDAQ:GERN) reported $-0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $-0.05 by $0.01 with surprise factor of 20%. In the most recent quarter, institutional ownership increased by a net of 2.06 million shares, or 3.29%.This is a bullish sign and indicates that institutions are feeling more optimistic about the outlook for GERN overall.48 holders increased their positions, 44 decreased their positions, and 35 holders held their positions. The firm's revenue for the quarter was down 96.8% on a year-over-year basis. It represents the number of a stock's shares that are being shorted by investors.

Stifel Nicolaus reaffirmed their hold rating on shares of Geron Corporation (NASDAQ:GERN) in a research report released on Friday, November 3rd. One research analyst has rated the stock with a sell rating, one has given a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. BTIG Research reaffirmed a "neutral" rating on shares of Geron a research note on Tuesday, September 20th. The company now has an average rating of "Buy" and an average target price of $5.00.

TRADEMARK VIOLATION WARNING: This article was first reported by Week Herald and is the sole property of of Week Herald. If you are accessing this article on another publication, it was illegally copied and reposted in violation of US and global trademark & copyright laws.

Zlatan slammed on social media following 'arrogant' tweet about Sweden
Another footballing giant has missed out on next summer's World Cup , and this time it is four-time world champions Italy . Ibra is Marmite, but his imagination with the ball and raw presence deserves a final shot at the World Cup.

A number of large investors have recently made changes to their positions in GERN. Russell Investments Group Ltd. acquired a new position in shares of Geron Corporation in the 2nd quarter worth approximately $114,000.

Wall Street analysts are predicting that Geron Corporation (NASDAQ:GERN) will report earnings per share of $-0.04 in their quarterly report. Parametric Portfolio Associates LLC raised its stake in shares of Geron Corporation by 59.4% in the second quarter. IHT Wealth Management LLC bought a new position in shares of Geron Corporation in the second quarter worth about $122,000. Parametric Portfolio Associates LLC now owns 47,976 shares of the biopharmaceutical company's stock worth $133,000 after acquiring an additional 17,877 shares in the last quarter. California State Teachers Retirement System now owns 240,167 shares worth $524,000. Bank of America Corp DE now owns 65,403 shares of the biopharmaceutical company's stock worth $148,000 after buying an additional 13,698 shares during the period.

Geron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc (Janssen). Using its nucleic acid chemistry, Geron designed Imetelstat to be an oligonucleotide that binds with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity.